Cite
HARVARD Citation
Georgatzakou, H. et al. (n.d.). Pathophysiological aspects of red blood cells in end‐stage renal disease patients resistant to recombinant human erythropoietin therapy. European journal of haematology. pp. 590-600. [Online].